Sublingual vs oral immunotherapy for food allergy: Identifying the right approach

Drugs

Volumn 72, Issue 15, 2012, Pages 1977-1989

  Narisety, Satya D ^a   Keet, Corinne A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Food allergy immunotherapies; Food hypersensitivity; Oral; Peanut hypersensitivity; Sublingual

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTOGLOBULIN; CASEIN; EGG PROTEIN; HAZELNUT ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; KIWIFRUIT EXTRACT; MILK PROTEIN; PEACH LIPID TRANSFER PROTEIN PRU P; PEANUT PROTEIN; PLANT EXTRACT; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALLERGEN IMMUNOTHERAPY; ANGIONEUROTIC EDEMA; CLINICAL PROTOCOL; COUGHING; CYTOKINE PRODUCTION; DESENSITIZATION; DIET RESTRICTION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; EGG ALLERGY; FOOD ALLERGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HAZELNUT; HAZELNUT ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INCIDENCE; KIWIFRUIT; KIWIFRUIT ALLERGY; LYMPHOCYTOPOIESIS; MILK ALLERGY; MOUTH DISEASE; ORAL IMMUNOTHERAPY; ORAL PRURITUS; OROPHARYNGEAL PRURITUS; OROPHARYNX DISEASE; PATIENT SELECTION; PEACH; PEACH ALLERGY; PEANUT ALLERGY; PRICK TEST; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT DISEASE; REVIEW; RHINOCONJUNCTIVITIS; SKIN MANIFESTATION; SORE THROAT; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW; TH2 CELL; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICARIA; WHEEZING;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E;

EID: 84867324865     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11640800-000000000-00000     Document Type: Review

References (43)

1. Boyce J, Assa'ad AH, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 2010; 126 (6 Suppl.): S1-58
2. Branum AM, Lukacs SL. Food allergy among U.S. children: trends in prevalence and hospitalizations. NCHS Data Brief 2008 Oct; (10): 1-8
3. Sicherer SH, Munoz-Furlong A, Godbold JH, et al. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125 (6): 1322-6
4. Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122 (6): 1161-5
5. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107 (1): 191-3 (Pubitemid 32105265)
6. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119 (4): 1016-8 (Pubitemid 46527814)
7. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010; 125 (2): S116-25
8. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127: 18-27
9. Viswanathan RK, Busse WW. Allergen immunotherapy in allergic respiratory diseases: from mechanisms to metaanalysis. Chest 2012; 141 (5): 1303-14
10. Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90 (2): 256-62
11. Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99 (6 Pt 1): 744-51 (Pubitemid 27280363)
12. Allam JP, Stojanovski G, Friedrichs N, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008; 63: 720-7 (Pubitemid 351591847)
13. Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA 2010; 303 (18): 1848-56
14. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow's milk allergy: a systematic review and meta-analysis. Clin Exp Allergy 2012; 42 (3): 363-74
15. Skripak JM, Matsui EC, Mudd K, et al. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2007; 120 (5): 1172-7 (Pubitemid 350029907)
16. Savage JH,Matsui EC, Skripak JM, et al. The natural history of egg allergy. J Allergy Clin Immunol 2007; 120 (6): 1413-7 (Pubitemid 350216612)
17. Skolnick HS, Conover-Walker MK, Koerner CB, et al. The natural history of peanut allergy. J Allergy Clin Immunol 2001; 107 (2): 367-74 (Pubitemid 32173917)
18. Patriarca G, Nucera E, Roncallo C, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003; 17 (3): 459-65 (Pubitemid 36259410)
19. Meglio P, Bartone E, Plantamura M, et al. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004; 59 (9): 980-7 (Pubitemid 39141411)
20. Staden U, Rolinck-Werninghaus C, Brewe F, et al. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007; 62 (11): 1261-9 (Pubitemid 47537518)
21. Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119 (1): 199-205 (Pubitemid 46037808)
22. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008; 121 (2): 343-7
23. Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008; 122 (6): 1154-60
24. Clark AT, Islam S, King Y, et al. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64 (8): 1218-20
25. Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124 (2): 292-300
26. Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126 (1): 83-91
27. Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010; 105: 376-81
28. Martorell A, De la Hoz B, Ibanez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy 2011; 41 (9): 1297-304
29. Garcia Rodriguez R, Urra JM, Feo-Brito F, et al. Oral rush desensitization to egg: efficacy and safety. Clin Exp Allergy 2011; (41): 1289-96
30. Anagnostau K, Clark A, King Y, et al. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 2011; 41: 1273-81
31. Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367: 233-43
32. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, doubleblind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116 (5): 1073-9 (Pubitemid 41571791)
33. De Boissieu D, Dupont C. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy 2006; 61 (10): 1238-9 (Pubitemid 44326366)
34. Fernandez-Rivas M, Garrido FS, Nadal JA, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64 (6): 876-83
35. Kim EH, Bird JA, Kulis M, et al. Sublingual immunotherapy for peanut allergy: clinical and immunological evidence of desensitization. J Allergy Clin Immunol 2011; 127 (3): 640-6.e1
36. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012 Feb; 129 (2): 448-55, 455.e1-5
37. Narisety SD, Skripak JM, Steele P, et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2009; 124 (3): 610-2
38. Hofmann AM, Scurlock AM, Jones SM, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124 (2): 286-91. 291 e281-286
39. Varshney P, Steele PH, Vickery BP, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009; 124 (6): 1351-2
40. Mempel M, Rakoski J, Ring J, et al. Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 2003; 111 (6): 1406-140
41. Kerzl R, Simonowa A, Ring J, et al. Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 2007; 119 (2): 507-8 (Pubitemid 46204805)
42. Enrique E, Malek T, Pineda F, et al. Sublingual immunotherapy for hazelnut food allergy: a follow-up study. Ann Allergy Asthma Immunol 2008; 100 (3): 283-4 (Pubitemid 351398010)
43. Narisety SD, Keet CA, Guerrerio P, et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy [abstract]. J Allergy Clin Immunol 2012 Feb; 129 (2 Suppl.): AB27